|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02161 JBM HEALTHCARE
Nominal 
1.410 +0.010 (+0.714%) | 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Turnover | 398,953 | 22.068% | 648,415 | 520,323 | 406,139 | 397,158 |
| Cost of Sales | (193,065) | 23.993% | (310,334) | (314,814) | (244,629) | (198,725) |
| Gross Profit | 205,888 | 20.316% | 338,081 | 205,509 | 161,510 | 198,433 |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (245) | -73.656% | (817) | (1,933) | (1,791) | (1,186) | |
| Profit / (Loss) before Taxation | 118,382 | 46.632% | 164,890 | 76,898 | 30,745 | 41,681 | |
| Taxation | (19,106) | 17.938% | (27,680) | (13,570) | (7,417) | (11,062) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,395) | 63.772% | (6,747) | (6,235) | 1,292 | (8,019) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 95,881 | 53.505% | 130,463 | 57,093 | 24,620 | 22,600 | |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Net Finance Costs / (Income) | 2,493 | -30.923% | 7,736 | 7,937 | 6,389 | 7,234 |
| Depreciation & Amortisation | 23,955 | -0.250% | 46,521 | 43,632 | 47,783 | 43,602 |
| Directors' Emoluments | -- | -- | 14,391 | 3,822 | 4,406 | 4,201 |
| 2024/09 - Interim | %Chg (Compare to Interim) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/09 - Interim | %Chg (Compare to Interim) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| EPS (cts) | 11.630 | 69.287% | 14.760 | 6.410 | 2.750 | 2.780 |
| DPS (cts) | 5.500 | -- | 7.500 | 3.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 47.291% | -- | 50.813% | 46.802% | -- | -- |
| Cash flow per share ($) | -- | -- | 0.216 | 0.163 | 0.067 | 0.072 |
| NBV per share ($) | 1.231 | -- | 1.164 | 1.079 | 1.040 | 1.012 |
| Remarks: | Real time quote last updated: 21/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 95,881,000 |
| %Change | 53.505% |
| EPS / (LPS) | HKD 0.116 |
| NBV Per Share ($) | HKD 1.231 |